Shotland Abigail M, Fontenot Andrew P, McKee Amy S
Division of Allergy and Clinical Immunology, Department of Medicine, and.
Department of Microbiology and Immunology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado.
Am J Respir Cell Mol Biol. 2021 May;64(5):547-556. doi: 10.1165/rcmb.2020-0420TR.
Over the last several decades, our understanding of regulated-cell-death (RCD) pathways has increased dramatically. In addition to apoptosis and accidental cell death (primary necrosis), a diverse spectrum of RCD pathways has been delineated. In the lung, airway macrophages are critical for maintaining the functionality of airways via the clearance of inhaled particles, cell debris, and infectious agents. Exposure of these cells to pathogenic organisms or particles can induce a variety of RCD pathways that promote the release of danger signals into the lung. These responses have evolved to trigger the innate and adaptive arms of the immune system and thus offer protection against pathogens; yet they can also contribute to the development of lung injury and pathogenic immune responses. In this review, we discuss recent studies that suggest a critical role for airway-macrophage RCD pathways in promoting the release of pulmonary danger signals in health and disease.
在过去几十年中,我们对程序性细胞死亡(RCD)途径的理解有了显著提高。除了凋亡和意外细胞死亡(原发性坏死)外,还描绘了各种各样的RCD途径。在肺部,气道巨噬细胞对于通过清除吸入颗粒、细胞碎片和病原体来维持气道功能至关重要。这些细胞暴露于致病生物或颗粒可诱导多种RCD途径,促进危险信号释放到肺部。这些反应已经进化到触发免疫系统的固有和适应性分支,从而提供针对病原体的保护;然而,它们也可能导致肺损伤和致病性免疫反应的发展。在这篇综述中,我们讨论了最近的研究,这些研究表明气道巨噬细胞RCD途径在促进健康和疾病状态下肺部危险信号释放方面起着关键作用。